Insurers pitch new ways to pay for million dollar therapies

Wall Street Journal

5 September 2019 - Cigna and CVS Health are developing new programs to help employers afford gene therapies that can cost more than $2 million.

Insurers are scrambling to blunt the expense of new drugs that can carry prices of more than $2 million per treatment, offering new setups aimed at making the cost of gene therapies more manageable for employers.

Cigna announced Thursday a new program that allows employers and insurers to pay per-month fees for a service that will cover the cost of gene therapies and manage their use. CVS Health says it plans to offer a new layer of coverage specifically for gene therapies, which would handle employers’ costs above a certain threshold. Anthem said it is looking at special insurance setups to help employers protect themselves from the financial impact of the drugs.

Read Wall Street Journal article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Funding , Budget , Gene therapy